# Aprea Therapeutics, Inc. — Form D

Aprea Therapeutics, Inc. of DOYLESTOWN, PA, a company, filed a Form D exempt-offering notice with the SEC on 2025-12-29. The offering totals $5.8M, of which $3.1M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2025-12-29
- Form: D
- Accession: 0001781983-25-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.8M
- Amount sold: $3.1M
- Remaining: $2.7M
- Investors: 8
- Date of first sale: 2025-12-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-568049

## Issuer

- Name: Aprea Therapeutics, Inc.
- CIK: 0001781983
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 3805 OLD EASTON ROAD, DOYLESTOWN, PA, 18902
- Phone: 215-948-4119

## Officers, directors & promoters (11)

| Name | Role | Location |
| --- | --- | --- |
| Jean-Pierre P Bizzari | Director | Doylestown, PA |
| Marc P Duey | Director | Doylestown, PA |
| Oren Gilad | Director | Doylestown, PA |
| Michael P Grissinger | Director | Doylestown, PA |
| Gabriela P Gruia | Director | Doylestown, PA |
| John B Henneman | Director | Doylestown, PA |
| Rifat B Pamukcu | Director | Doylestown, PA |
| Richard P Peters | Director | Doylestown, PA |
| Bernd B Seizinger | Director | Doylestown, PA |
| Oren Gilad | Executive Officer | Doylestown, PA |
| John P Hamill | Executive Officer | Doylestown, PA |

## More

- [CIK 1781983 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1781983&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001781983-25-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.